Valeo Financial Advisors, LLC Verastem, Inc. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$0.39 - $0.71 $9,165 - $16,685	23,500 New	23,500 $9,000
Q2 2022 Aug 03, 2022	BUY	$1.02 - $1.83 $1,020 - $1,830	1,000 Added 4.44%	23,500 $27,000
Q4 2021 Jan 07, 2022	BUY	$2.05 - $3.2 $13,324 - $20,800	6,500 Added 40.63%	22,500 $46,000
Q1 2021 Apr 12, 2021	BUY	$1.9 - $2.82 $19,000 - $28,200	10,000 Added 166.67%	16,000 $40,000
Q2 2020 Jul 20, 2020	BUY	$1.69 - $4.2 $10,140 - $25,200	6,000 New	6,000 $10,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.